Cardiff Oncology, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cardiff Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2025.
  • Cardiff Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $1.68M, a 42.7% increase year-over-year.
  • Cardiff Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $5.51M, a 32.1% increase year-over-year.
  • Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $4.76M, a 5.57% increase from 2023.
  • Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.51M, a 5.95% increase from 2022.
  • Cardiff Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.26M, a 31.6% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $5.51M $1.68M +$504K +42.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-29
Q1 2025 $5M $1.37M +$241K +21.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $4.76M $1.2M +$295K +32.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $4.47M $1.25M +$298K +31.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.17M $1.18M -$402K -25.4% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-29
Q1 2024 $4.57M $1.12M +$60K +5.64% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $4.51M $909K -$103K -10.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $4.61M $955K -$82K -7.91% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $4.69M $1.58M +$526K +49.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $4.17M $1.06M -$88K -7.64% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $4.26M $1.01M +$22K +2.22% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $4.23M $1.04M +$97K +10.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $4.14M $1.06M +$19K +1.83% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $4.12M $1.15M +$884K +330% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $3.23M $990K +$46K +4.87% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $3.19M $940K +$578K +160% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.61M $1.04M +$754K +267% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.86M $268K +$91K +51.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.77M $944K +$674K +250% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $1.09M $362K +$95.7K +35.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $995K $282K +$133K +89.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $862K $177K -$23.1K -11.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $885K $270K +$742 +0.28% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $884K $266K -$11.9K -4.28% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $896K $149K -$72.5K -32.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $969K $200K -$1.21M -85.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $2.17M $269K -$626K -70% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $2.8M $278K -$1.14M -80.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $3.94M $221K -$554K -71.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $4.5M $1.41M +$485K +52.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $4.01M $895K -$667K -42.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $4.68M $1.42M -$408K -22.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $5.09M $775K -$527K -40.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $5.61M $921K -$1.89M -67.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $7.5M $1.56M +$375K +31.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 $7.13M $1.83M +$906K +98.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $6.22M $1.3M +$178K +15.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $6.05M $2.81M +$2.1M +295% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $3.95M $1.19M +$502K +73.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 $3.44M $924K +$518K +128% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $2.93M $1.12M +$704K +168% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $2.22M $712K +$152K +27.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $2.07M $685K +$364K +113% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $1.71M $406K -$563K -58.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $2.27M $419K +$72.1K +20.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $2.2M $560K +$218K +63.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $1.98M $321K +$138K +75.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $1.84M $969K +$839K +643% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $1M $347K +$232K +200% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $771K $341K +$239K +232% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $532K $183K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $130K +$47.4K +57.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $116K +$55.5K +92.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $103K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 $83K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $60.3K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.